Jinan GSY Biotechnology Co., LTD. is a leading high-tech enterprise specializing in the research, development, production, and sales of veterinary medicines, pet care products, and nutritional supplements. With pet ownership growing steadily worldwide, the demand for advanced and reliable pet medicine has surged. GSY stands out in this competitive market by combining innovation, high-level research capabilities, and modern production practices. The company is widely recognized for its technical expertise and has established itself as a trusted provider in the field of animal biomedicine for both domestic and international clients.

From the outset, GSY has invested heavily in innovation and quality. The company’s modern production equipment and efficient processes provide a strong foundation for its operations. Its technical advantages lie in medicine development, preparation processes, and strict quality control. This ensures that every product meets high industry standards and delivers consistent results for end users.

GSY’s contributions to the industry have been recognized with numerous accolades. It has been awarded the title of National High-Tech Enterprise, National Intellectual Property Advantage Enterprise, and Shandong “Gazelle Enterprise.” The company also operates as a Shandong Postdoctoral Innovation Practice Base and participates in initiatives aimed at rural revitalization and specialized industry development. These distinctions highlight GSY’s commitment not only to scientific excellence but also to contributing positively to society and regional growth.

The company’s philosophy is rooted in “scientific management and integrity.” With this principle, GSY continues to explore new technologies and products. Strategic collaborations with top academic institutions such as Shandong University, Qilu University of Technology, and Shandong University of Traditional Chinese Medicine further strengthen its capabilities. Through these partnerships, GSY maintains an active research and development center covering more than 1,300 square meters. This center is equipped with state-of-the-art instruments, including Waters UPLC, Thermo Scientific systems, UV and infrared spectrophotometers, and microbial detection devices.

The R&D center houses multiple independent laboratories, such as pharmaceutical preparation, stability testing, and traditional Chinese medicine research rooms. In addition, the company operates ten pilot and industrial production workshops designed to meet the requirements for new veterinary medicine development. This integrated setup allows GSY to quickly transform research achievements into practical, market-ready products.

GSY has successfully developed a wide range of veterinary and pet products with independent intellectual property rights. To date, the company has secured 86 veterinary medicine product approvals, 37 patents, and multiple new veterinary medicine classifications from the Ministry of Agriculture. Some of its most notable products include:

• Fipronil Drops for Cats – The first domestically produced product of its kind in China, reducing reliance on imported deworming medicines and breaking international monopolies.

• Cefpodoxime Proxetil Tablets – A national new veterinary medicine with broad-spectrum antibacterial properties.

• Imidacloprid and Moxidectin Drops – A unique formulation targeting 12 parasites with 28 treatment indications.

• Isoflurane – A new-generation anesthetic produced under ultra-low temperature conditions, designed to minimize side effects.

These achievements demonstrate GSY’s ability to combine independent innovation with international technology, ensuring its products meet global standards. As a result, GSY has expanded its reach to more than 30 countries across Europe, America, South Asia, and Southeast Asia. The company regularly participates in major international trade fairs, including the Nuremberg International Trade Fair for Pet Suppliers, the Asia Pet Exhibition, and the Bologna International Pet Products Show, among others.

GSY’s vision extends beyond business. Guided by the mission of “pursuing excellence and contributing to society,” the company is committed to developing green veterinary medicines that protect animal health and indirectly serve human well-being. This dedication reflects the values of its leadership and the long-term strategy of building a responsible, forward-thinking enterprise.